Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9,898 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The 2011 EBCTCG polychemotherapy overview.
Palmieri C, Jones A. Palmieri C, et al. Among authors: jones a. Lancet. 2012 Feb 4;379(9814):390-2. doi: 10.1016/S0140-6736(11)61823-0. Epub 2011 Dec 5. Lancet. 2012. PMID: 22152852 No abstract available.
Carcinoid tumour.
Caplin ME, Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs AK. Caplin ME, et al. Among authors: jones al. Lancet. 1998 Sep 5;352(9130):799-805. doi: 10.1016/S0140-6736(98)02286-7. Lancet. 1998. PMID: 9737302 Review.
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy.
Jones AL, Hill AS, Soukop M, Hutcheon AW, Cassidy J, Kaye SB, Sikora K, Carney DN, Cunningham D. Jones AL, et al. Lancet. 1991 Aug 24;338(8765):483-7. doi: 10.1016/0140-6736(91)90554-3. Lancet. 1991. PMID: 1678453 Clinical Trial.
An update on the medical management of breast cancer.
Yeo B, Turner NC, Jones A. Yeo B, et al. Among authors: jones a. BMJ. 2014 Jun 9;348:g3608. doi: 10.1136/bmj.g3608. BMJ. 2014. PMID: 24912480 Review. No abstract available.
A shift in the treatment of hormone receptor and human epidermal growth factor receptor 2-positive metastatic breast cancer.
Kemp Z, Jones A. Kemp Z, et al. Among authors: jones a. Adv Ther. 2011 Aug;28(8):603-14. doi: 10.1007/s12325-011-0050-0. Epub 2011 Aug 8. Adv Ther. 2011. PMID: 21833702 Review.
Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.
Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA. Ring AE, et al. Among authors: jones a. J Clin Oncol. 2005 Jun 20;23(18):4192-7. doi: 10.1200/JCO.2005.03.038. J Clin Oncol. 2005. PMID: 15961766
Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study.
Mansi JL, Yellowlees A, Lipscombe J, Earl HM, Cameron DA, Coleman RE, Perren T, Gallagher CJ, Quigley M, Crown J, Jones AL, Highley M, Leonard RC, Evans TR. Mansi JL, et al. Among authors: jones al. Breast Cancer Res Treat. 2010 Aug;122(3):787-94. doi: 10.1007/s10549-010-0989-6. Epub 2010 Jun 18. Breast Cancer Res Treat. 2010. PMID: 20559708 Clinical Trial.
Management of breast cancer--Part II.
Turner NC, Jones AL. Turner NC, et al. BMJ. 2008 Jul 11;337(7662):a540. doi: 10.1136/bmj.a540. BMJ. 2008. PMID: 18621762 Free PMC article. Review. No abstract available.
Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01.
Langley RE, Carmichael J, Jones AL, Cameron DA, Qian W, Uscinska B, Howell A, Parmar M. Langley RE, et al. Among authors: jones al. J Clin Oncol. 2005 Nov 20;23(33):8322-30. doi: 10.1200/JCO.2005.01.1817. J Clin Oncol. 2005. PMID: 16293863 Clinical Trial.
Optimizing treatment of HER2-positive metastatic breast cancer.
Jones AL, Leyland-Jones B. Jones AL, et al. Semin Oncol. 2004 Oct;31(5 Suppl 10):29-34. doi: 10.1053/j.seminoncol.2004.07.019. Semin Oncol. 2004. PMID: 15490372
9,898 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback